Paul Campanelli, EVP, Pres-Par Pharmaceutical at PAR PHARMACEUTICAL COMPANIES, INC. (PRX), sold 15,068 shares at $31.18 ($466K) on 2011-03-07, disclosed to the SEC on 2011-03-09.
Seasonal sale ($466k) by EVP, Pres-Par Pharmaceutical — this insider has traded PRX in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.95 | 700 | $22K | 4.7% |
| 2 | $30.96 | 1,000 | $31K | 6.7% |
| 3 | $30.96 | 900 | $28K | 6.0% |
| 4 | $30.98 | 100 | $3K | 0.7% |
| 5 | $30.99 | 162 | $5K | 1.1% |
| 6 | $31.01 | 200 |
| $6K |
| 1.3% |
| 7 | $31.02 | 100 | $3K | 0.7% |
| 8 | $31.03 | 101 | $3K | 0.7% |
| 9 | $31.04 | 833 | $26K | 5.6% |
| 10 | $31.04 | 200 | $6K | 1.3% |
| 11 | $31.05 | 1,966 | $61K | 13.1% |
| 12 | $31.05 | 1,350 | $42K | 9.0% |
| 13 | $31.06 | 800 | $25K | 5.3% |
| 14 | $31.13 | 6 | $187 | 0.0% |
| 15 | $31.16 | 100 | $3K | 0.7% |
| 16 | $31.17 | 600 | $19K | 4.0% |
| 17 | $31.18 | 900 | $28K | 6.0% |
| 18 | $31.19 | 400 | $12K | 2.7% |
| 19 | $31.19 | 300 | $9K | 2.0% |
| 20 | $30.39 | 100 | $3K | 0.7% |
| 21 | $30.41 | 100 | $3K | 0.7% |
| 22 | $30.42 | 100 | $3K | 0.7% |
| 23 | $30.43 | 200 | $6K | 1.3% |
| 24 | $30.45 | 100 | $3K | 0.7% |
| 25 | $30.47 | 100 | $3K | 0.7% |
| 26 | $30.50 | 550 | $17K | 3.6% |
| 27 | $30.52 | 500 | $15K | 3.3% |
| 28 | $30.53 | 1,100 | $34K | 7.2% |
| 29 | $30.54 | 1,000 | $31K | 6.6% |
| 30 | $30.56 | 500 | $15K | 3.3% |
| Total | $30.90 avg | 15,068 | $466K | 100% |
| Filing → |
| ENDP | BUY | 2016-05-11 | $202K | — | Filing → |
| ENDP | BUY | 2015-11-12 | $117K | — | Filing → |
| PRX | SELL | 2011-03-09 | $1.5M | — | Filing → |